Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes: A potential role for the acidic sphingomyelinase pathway in normal immunoregulation

Journal of Clinical Investigation

Volumn 97, Issue 2, 1996, Pages 316-322

  De Maria, Ruggero ^a   Boirivant, Monica ^b   Cifone, Maria Grazia ^c   Roncaioli, Paola ^c   Hahne, Michael ^d   Tschopp, Jurg ^d   Pallone, Francesco ^e   Santoni, Angela ^b   Testi, Roberto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

Acidic sphingomyelinase; CD95; Fas APO 1; Gut mucosa; T LPL

Indexed keywords

CD45 ANTIGEN; CELL SURFACE RECEPTOR; CERAMIDE; FAS ANTIGEN; LIGAND; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CROSS LINKING; ETIOLOGY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD45; ANTIGENS, CD95; APOPTOSIS; CERAMIDES; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; MEMBRANE GLYCOPROTEINS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; T-LYMPHOCYTES;

EID: 0030050848     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118418     Document Type: Article

References (47)

1. Fiocchi, C. 1989. Mucosal Immunity. Gastroenterology Int. 2:172-179.
2. Brandtzaeg, P., T S Halstesten, K Kett, P Krajci, D Kvale, T. O. Rognum, H. Scott, and L M. Sollid 1989. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology. 97:1562-1584.
3. Qiao, L , G. Schurmann, M Betzler, and S. C. Meuer. 1991. Activation and signaling status of human lamina propria T lymphocytes Gastroenterology. 101:1529-1536.
4. De Maria, R., S. Fais, M. Silvestri, L. Frati, F. Pallone, A Santoni, and R. Testi. 1993. Continuous in vivo activation and transient hyporesponsiveness to TCR/CD3 triggering of human gut lamina propria T lymphocytes. Eur. J. Immunol. 23:3104-3108
5. Qiao, L., G. Schurmann, F. Autschhach, R. Wallich, and S. C. Meuer. 1993. Human intestinal mucosa alters T-cell reactivities. Gastroenterology 105: 814-819.
6. Kabelitz, D., T. Pohl, and K. Pechhold. 1993 Activation induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today 14: 338-339.
7. - intraepithelial lymphocytes by apoptosis. Eur. J. Immunol. 20:2809-2812.
8. Nagata, S., and P Golstein. 1995. The Fas death factor. Science (Wash. DC). 267 1449-1456.
9. Krammer, P. H., J. Dhein, H. Walczak, I. Berhmann, S. Manani, B. Matiba, M. Fath, P. Daniel, E. Knipping, M O Estendorp et al. 1994. The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142:175-191.
10. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood J Immunol. 149 3753-3758.
11. Klas, C., K -M. Debatin, R R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625-630.
12. Suda, T , T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the Tumor Necrosis Factor family. Cell. 75:1169-1178.
13. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J Martin, W. R. Force, D H. Lynch, C. F. Ware, and D. R. Green 1995. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond). 373:441-444.
14. Dhein, J., H. Watczak, C. Baumler, K.-M. Debatin, and P. H. Krammer. 1995 Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature (Lond.) 373:438-441.
15. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med. 181:71-77.
16. Cifone, M. G , R. De Maria, P. Roncaioli, M. R. Rippo, M. Azuma, L. L Lanier, A Santoni, and R. Testi. 1994. Apoptotic signaling through CD95 (Fas/APO-1) activates an acidic sphingomyelinase. J Exp Med. 180:1547-1552.
17. Gulbins, E., R. Bissonette, A Mahboubi, S. Martin, W. Nishioka, T. Brunner, G Baier, G. Baier-Bitterlich, C Byrd, F Lang, R. Kolesnick, A. Altman, and D. Gieen. 1995. Fas-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway Immunity 2:341-351.
18. Watanabe-Fukunaga, R., C I Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond) 356:314-317.
19. Singer, G. G., and A. K Abbas 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity, 1:365-371.
20. Fais, S., M R. Capobianchi, F. Pallone, P. DiMarco, M. Boirivant, F. Dianzani, and A. Torsoli. 1991. Spontaneous release of interferon γ by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to Interferon γ inducers. Gut. 32:403-407.
21. Hahne, M., M. C Peitsch, M Irmler, M Schroter, B Lowin. M Rousseau, C Bron, T Renno, L French, and J Tschopp. 1995. Characterization of the non-functional Fas ligand of gld mice. Internat Immunol. In press.
22. Preiss, J., C. R. Loomis, W. R. Bishop, R. Stein, J. E. Niedel, and R M Bell. 1986. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes and ras- and sis-transformed normal rat kidney cells. J. Biol Chem 261:8597-8600.
23. Wiegmann, K., S. Schutze, T. Machleidt, D. Witte, and M. Kronke 1994. Functional dichotomy of neutral and acidic sphingomyelmases in tumor necrosis factor signaling. Cell. 78:1005-1015.
24. Smart, C. J., R. V. Heatley, and L. K. Trejdosiewicz. 1989. Expression of CD6 and the UCHL1-defined CD45 (p180) antigen by human colonic T lymphocytes Immunology. 66:90-95.
25. Schieferdeeker, H. L., R Ullrich, H. Hirseland, and M. Zeitz. 1992. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J. Immunol. 149:2816-2822.
26. Mackay, C. H. 1993 Homing of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5:423-427.
27. Hannun, Y. A. 1994. The sphingomyelin cycle and second messenger function of ceramide. J. Biol. Chem 269.3125-3128.
28. Kolesnick, R., and D. W. Golde. 1994. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling Cell 77:325-328.
29. Obeid, L. M., C. M. Linardic, L A. Karolak, and Y. A. Hannun. 1993 Programmed cell death induced by ceramide. Science (Wash. DC) 259 1769-1771.
30. Krammer, P H., I. Behrmann, P. Daniel, J. Dhein, and K.-M Debatin 1994 Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6 279-289.
31. Crispe, N 1994. Fatal interactions: Fas-induced apoptosis of mature T cells Immunity. 1:347-349.
32. Vignaux, F., and P. Golstein. 1994 Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway Eur. J. Immunol 24:923-927.
33. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. Ei-Khatib, D. H. Sherr B Z Stanger, and A. Marshak-Rothstem. 1995. Fas(CD95)/Fas interactions required for programmed cell death after T-cell activation. Nature (Lond) 373 444-448.
34. Kim, M.-Y. C Linardic, L Obeid, and Y Hannun. 1991. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and γ-interferon Specific role in cell differentiation J Biol Chem. 26:484-489.
35. Dressier, K. A , S. Mathias, and R. N. Kolesnick. 1992. Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell free system. Science (Wash. DC) 255:1715-1718.
36. Schütze, S., K. Potthof, T. Machleidt, D. Berkovic, K Wiegmann, and M Krönke. 1992. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71 765-776.
37. Mathias, S , A Younes, C.-C. Kan, I. Orlow, C. Joseph, and R. N Kolesnick. 1993. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science (Wash DC) 259:519-522.
38. Dobrowsky, R. T , M. H. Werner, A. M. Castellino, M. V. Chao, and Y. A Hannun. 1994. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science (Wash DC). 265:1596-1599.
39. Mathias, S., and R Kolesnick 1993. Ceramide: a novel second messenger. Adv Lipid Res. 25:65-90.
40. Mathias S., K. A Dressler, and R. N. Kolesnick. 1991. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor α. J. Biol Chem 88:10008-10013.
41. Raines, M A , R. N. Kolesnick, and D. W. Golde 1993. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J Biol. Chem. 268:14572-14575
42. Dobrowsky, R. T., C. Kamibayashi, M C. Mumby, and Y A. Hannun. 1993. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 268:15523-15530.
43. Machleidt, T., K Wiegmann, T. Henkel, S. Schütze, P. Baeuerle, and M. Krönke. 1994 Sphingomyelinase activates proteolytic lκB-α degradation in a cell-free system. J Biol. Chem. 269: 13760-13765
44. Yang, Z , M. Costanzo, D. W. Golde, and R. N. Kolesnick. 1993 Tumor necrosis factor activation of the sphingomyelin pathway signals Nuclear Factor κB translocation in intact HL-60 cells. J Biol. Chem 268:20520-20523.
45. Jarvis, W. D., R N. Kolesnick, F. A. Fornari, R. S. Traylor, D. A. Gerwitz, and S. Grant. 1994. Induction of apoptotic damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci USA 91:73-77.
46. Ramsdell, F., M. S. Seaman, R. E. Miller, K. S. Picha, M K Kennedy, and D. H Lynch. 1994. Differental ability of Th1 and Th2 cells to express Fas ligand and to undergo activation induced cell death Int Immunol 6:1545-1553.
47. Mariam, S M., B Matiba, C. Baumler, and P. H. Krammer. 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J Immunol. 25:2303-2307.